ANGELALIGN (06699) surged 5.40% during Thursday's intraday session, reflecting strong investor optimism following the company's recent regulatory milestone.
The clear aligner specialist obtained the MDR-CE certificate from TÜV SÜD, confirming its products meet the EU's stringent Medical Device Regulation requirements. This certification marks a critical step in ANGELALIGN's international expansion, as it enables access to high-standard European markets and enhances the company's global credibility.
CEO Hu Jiezhang highlighted that international cases now represent over 50% of total case volume, with operations spanning 60+ countries. The MDR-CE certification is expected to further strengthen ANGELALIGN's competitive position in the global clear aligner market.
Comments